Jacobi Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $456K | Sell |
1,180
-259
| -18% | -$96.1K | 0.02% | 468 |
|
|
2026
Q1 | $421K | Sell |
1,439
-192
| -12% | -$63.1K | 0.02% | 453 |
|
|
2025
Q4 | $572K | Sell |
1,631
-126
| -7% | -$42.6K | 0.03% | 379 |
|
|
2025
Q3 | $568K | Buy |
1,757
+446
| +34% | +$139K | 0.03% | 367 |
|
|
2025
Q2 | $510K | Buy |
1,311
+247
| +23% | +$99.3K | 0.03% | 376 |
|
|
2025
Q1 | $463K | Buy |
1,064
+182
| +21% | +$73.1K | 0.03% | 373 |
|
|
2024
Q4 | $325K | Buy |
882
+27
| +3% | +$11.3K | 0.02% | 455 |
|
|
2024
Q3 | $445K | Buy |
855
+189
| +28% | +$101K | 0.03% | 376 |
|
|
2024
Q2 | $361K | Sell |
666
-32
| -5% | -$16.9K | 0.03% | 374 |
|
|
2024
Q1 | $362K | Buy |
698
+13
| +2% | +$6.46K | 0.03% | 357 |
|
|
2023
Q4 | $323K | Buy |
685
+39
| +6% | +$18K | 0.03% | 359 |
|
|
2023
Q3 | $281K | Buy |
646
+17
| +3% | +$7.71K | 0.03% | 361 |
|
|
2023
Q2 | $280K | Hold |
629
| – | – | 0.03% | 367 |
|
|
2023
Q1 | $289K | Sell |
629
-9
| -1% | -$4.28K | 0.03% | 351 |
|
|
2022
Q4 | $327K | Buy |
638
+52
| +9% | +$26.4K | 0.04% | 326 |
|
|
2022
Q3 | $266K | Hold |
586
| – | – | 0.04% | 346 |
|
|
2022
Q2 | $283K | Buy |
586
+40
| +7% | +$19.8K | 0.04% | 341 |
|
|
2022
Q1 | $268K | Sell |
546
-1
| -0.2% | -$457 | 0.03% | 361 |
|
|
2021
Q4 | $254K | Buy |
547
+25
| +5% | +$10.5K | 0.03% | 374 |
|
|
2021
Q3 | $195K | Buy |
522
+205
| +65% | +$77.9K | 0.02% | 397 |
|
|
2021
Q2 | $121K | Buy |
317
+32
| +11% | +$12.2K | 0.02% | 453 |
|
|
2021
Q1 | $102K | Buy |
285
+49
| +21% | +$15.8K | 0.02% | 451 |
|
|
2020
Q4 | $76K | Buy |
236
+38
| +19% | +$11.7K | 0.01% | 457 |
|
|
2020
Q3 | $53K | Buy |
198
+111
| +128% | +$29.9K | 0.01% | 487 |
|
|
2020
Q2 | $23K | Buy |
87
+53
| +156% | +$14.1K | ﹤0.01% | 616 |
|
|
2020
Q1 | $8K | Sell |
34
-15
| -31% | -$4.09K | ﹤0.01% | 740 |
|
|
2019
Q4 | $15K | Buy |
49
+47
| +2,350% | +$12.9K | ﹤0.01% | 675 |
|
|
2019
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1058 |
|
|
2019
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 977 |
|
|
2019
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 924 |
|
|
2018
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 898 |
|
|
2018
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 933 |
|
|
2018
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 1022 |
|
|
2018
Q1 | $0 | Buy |
+2
| New | +$470 | ﹤0.01% | 991 |
|
Other funds holding ELV
Jacobi Capital Management's ELV Position: Q2 2026 in Review
Jacobi Capital Management reduced its Elevance Health (ELV) stake by 18% in Q2 2026, selling an estimated $96.1K and leaving 1,180 shares worth $456K. The position accounts for 0.02% of the portfolio, ranked #468.
Jacobi Capital Management first reported a position in ELV in Q1 2018 and has held it in 34 quarters since. The position peaked at $572K in Q4 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Jacobi Capital Management held 1,180 shares of Elevance Health worth $456K as of Q2 2026.
- Jacobi Capital Management sold 259 Elevance Health shares in Q2 2026, an estimated $96.1K.
- Elevance Health made up 0.02% of Jacobi Capital Management's portfolio in Q2 2026, its #468 holding.
- Jacobi Capital Management first reported a position in Elevance Health in Q1 2018 and has held it in 34 quarters since.
- Jacobi Capital Management's Elevance Health position peaked at $572K in Q4 2025.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.